These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7003284)

  • 1. Naloxone reduces cigarette smoking.
    Karras A; Kane JM
    Life Sci; 1980 Oct; 27(17):1541-5. PubMed ID: 7003284
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of naloxone and schizophrenic auditory hallucinations.
    Freeman CP; Fairburn CG
    Psychol Med; 1981 May; 11(2):405-7. PubMed ID: 7022531
    [No Abstract]   [Full Text] [Related]  

  • 3. Negative naloxone effects in schizophrenic patients.
    Janowsky DS; Segal DS; Abrams A; Bloom F; Guillemin R
    Psychopharmacology (Berl); 1977 Aug; 53(3):295-7. PubMed ID: 19807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
    Kurland AA; McCabe OL; Hanlon TE; Sullivan D
    Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naloxone on hyperphagia in Prader-Willi syndrome.
    Kyriakides M; Silverstone T; Jeffcoate W; Laurance B
    Lancet; 1980 Apr; 1(8173):876-7. PubMed ID: 6103230
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone effects on manic symptoms and growth-hormone levels.
    Janowsky D; Judd L; Huey L; Roitman N; Parker D; Segal D
    Lancet; 1978 Aug; 2(8084):320. PubMed ID: 79114
    [No Abstract]   [Full Text] [Related]  

  • 8. Indication of an antipsychotic action of the opiate antagonist naloxone.
    Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone fails to reverse blood pressure in shock: a double blind study in man.
    Montastruc JL; Richard JP; Cathala B
    J Pharmacol; 1985; 16(3):313-4. PubMed ID: 3906280
    [No Abstract]   [Full Text] [Related]  

  • 10. Low- and high-dose naloxone in dementia of the Alzheimer type.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone may be beneficial in the treatment of tardive dyskinesia.
    Blum I; Munitz H; Shalev A; Roberts E
    Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154
    [No Abstract]   [Full Text] [Related]  

  • 12. [Naloxone as antidote in benzodiazepine poisoning].
    Hüttel MS; Christensen KN
    Ugeskr Laeger; 1979 Jul; 141(29):1979-81. PubMed ID: 44580
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of effect of naloxone on selection of nutrients by bulimic women.
    Soll E; Thomas B; Mitchell JE; Morley J
    Am J Psychiatry; 1989 Jun; 146(6):803. PubMed ID: 2729436
    [No Abstract]   [Full Text] [Related]  

  • 14. Naloxone versus placebo in treatment of septic shock.
    DeMaria A; Carven DE; Heffernan JJ; McIntosh TK; Grindlinger GA; McCabe WR
    Lancet; 1985 Jun; 1(8442):1363-5. PubMed ID: 2861315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of naloxone on acute stroke.
    Czlonkowska A; Cyrta B
    Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease.
    Perraro F; Tosolini G; Pertoldi F; Sbrojavacca R; Beorchia A; Bulfoni A; Del Fabbro L; Grassi L; Lestuzzi A; Mione V
    Lancet; 1984 Apr; 1(8382):915. PubMed ID: 6143225
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous naloxone administration in schizophrenia and affective illness.
    Davis GC; Bunney WE; DeFraites EG; Kleinman JE; van Kammen DP; Post RM; Wyatt RJ
    Science; 1977 Jul; 197(4298):74-7. PubMed ID: 325650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relief of intractable pruritus with naloxone.
    Bernstein JE; Swift R
    Arch Dermatol; 1979 Nov; 115(11):1366-7. PubMed ID: 389168
    [No Abstract]   [Full Text] [Related]  

  • 20. Naloxone in schizophrenia.
    Skrabanek P
    Lancet; 1982 Dec; 2(8310):1270. PubMed ID: 6128561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.